Gary Bourgeault
Long only, research analyst, portfolio strategy, media

American Vanguard Positioned For Solid, Long-Term Growth

American Vanguard Corp. (NYSE:AVD) has been getting punished recently because of its poor showing in the last quarter, where revenue was down, earnings missed, and operating expenses soared.

This isn't too worrisome, as it's the nature of a company serving the agriculture segment to sometimes experience these types of results because of weather and farmers cutting back on spending on certain crops.

Fortunately, it looks like the second half of 2013 will be much better, with sales of Metam, Bidrin, Dibrom, Vapam, and Folex expected to rise because of various conditions conducive to those products, including weather and pests.

Over the longer term its Impact herbicide and equity investment in life sciences company TyraTech, Inc. could drive sales...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details